Published in Ann Oncol on July 01, 2003
Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age--period--cohort approach. Br J Cancer (2005) 0.93
The decline in stomach cancer mortality: exploration of future trends in seven European countries. Eur J Epidemiol (2010) 0.92
Retracted Stomach cancer mortality in the future: where are we going? Int J Prev Med (2011) 0.89
Cancer mortality differences among urban and rural residents in Lithuania. BMC Public Health (2008) 0.84
Polonium and lung cancer. J Oncol (2011) 0.83
Nutrition deficiency increases the risk of stomach cancer mortality. BMC Cancer (2012) 0.82
Numerical solutions for a model of tissue invasion and migration of tumour cells. Comput Math Methods Med (2010) 0.81
Cancer mortality among men in Central Serbia: 1985-2006 survey study. Croat Med J (2008) 0.77
Plantago ovata consumption and colorectal mortality in Spain, 1995-2000. J Epidemiol (2009) 0.76
Efficacy and safety of acupuncture for chemotherapy-induced leucopoenia: protocol for a systematic review. BMJ Open (2016) 0.75
Europe's eye is fixed on mighty things. Ann Oncol (2003) 0.75
Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol (2007) 11.04
Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science (1995) 9.48
Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet (2001) 7.92
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
The European mesothelioma epidemic. Br J Cancer (1999) 6.28
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 5.94
Differences in hospital asthma management. Lancet (1988) 5.86
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Change in male:female ratio among newborn infants in Denmark. Lancet (1996) 4.85
Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology (1998) 4.58
HOOKLESS1, an ethylene response gene, is required for differential cell elongation in the Arabidopsis hypocotyl. Cell (1996) 4.48
Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet (1994) 4.38
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol (2002) 4.32
Overview of the main outcomes in breast-cancer prevention trials. Lancet (2003) 4.31
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Cancer in the European Community and its member states. Eur J Cancer (1990) 3.95
Sources of concern about the Patient Self-Determination Act. N Engl J Med (1991) 3.90
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet (1998) 3.83
Childhood leukaemia in northern Scotland. Lancet (1986) 3.69
Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans. Infect Immun (1984) 3.63
A study of proactive ethics consultation for critically and terminally ill patients with extended lengths of stay. Crit Care Med (1998) 3.57
Community infection ratio as an indicator for tuberculosis control. Lancet (1995) 3.53
Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology (1991) 3.38
Natural variation in the human sex ratio. Hum Reprod (1999) 3.27
Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer (2009) 3.27
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol (1999) 3.19
Bacteroides fragilis resistant to the administration of clindamycin. Am J Med (1976) 3.13
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol (2000) 2.97
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst (1999) 2.90
Theory-driven behavioral intervention research for the control of diarrheal diseases. Soc Sci Med (1992) 2.88
Intake of macronutrients and risk of breast cancer. Lancet (1996) 2.81
Management of asthma in hospital: a prospective audit. Br Med J (Clin Res Ed) (1988) 2.77
Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77
Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer (2006) 2.76
ABC of colorectal cancer: Epidemiology. BMJ (2000) 2.71
European cancer mortality predictions for the year 2013. Ann Oncol (2013) 2.71
Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol (1990) 2.69
Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. American Heart Association. Circulation (1997) 2.68
Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med (1997) 2.67
Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax (1993) 2.62
The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol (1990) 2.62
Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) (2012) 2.52
Epidemiology of biliary tract cancers: an update. Ann Oncol (2008) 2.51
Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res (1990) 2.49
Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet (1999) 2.48
A meta-analysis of alcohol drinking and cancer risk. Br J Cancer (2001) 2.47
Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol (2012) 2.45
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Rheumatoid arthritis and cancer risk. Eur J Cancer (1996) 2.44
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology (1999) 2.41
Finding a benchmark for monitoring hospital cleanliness. J Hosp Infect (2010) 2.40
Sexual factors and prostate cancer. BJU Int (2003) 2.38
A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol (1999) 2.36
The Elag-Koln automatic blood pressure recorder. A clinical appraisal. Br Heart J (1977) 2.34
Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart (2002) 2.34
The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int (2003) 2.32
Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32
Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens (2003) 2.25
Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer (2012) 2.24
Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol (1993) 2.23
Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch Intern Med (2001) 2.20
Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol (2009) 2.20
A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology (1991) 2.18
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg (1996) 2.15
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer (2012) 2.15
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis. Br J Dermatol (2014) 2.15
The effect of environmental tobacco smoke in two urban communities in the west of Scotland. Eur J Respir Dis Suppl (1984) 2.15
Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer (1991) 2.14
Tamoxifen for breast cancer among hysterectomised women. Lancet (2002) 2.11
Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology (2001) 2.10
Therapy for testicular cancer in Central and Eastern Europe. Lancet (1990) 2.08
Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J Infect Dis (1983) 2.08
A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control (1999) 2.08
Breast-feeding and diarrheal morbidity. Pediatrics (1990) 2.07
Light alcohol drinking and cancer: a meta-analysis. Ann Oncol (2012) 2.04
Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.04
Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol (2002) 2.03
Childhood cancer mortality in Italy. Lancet (1996) 2.02
Public health. The cholera crisis in Africa. Science (2009) 2.02
A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique. Ann Surg (1996) 2.00
Decline in sex ratio at birth after Kobe earthquake. Hum Reprod (1998) 1.98
Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Ann Oncol (2001) 1.95
Fish consumption and cancer risk. Am J Clin Nutr (1999) 1.94
The epidemiology of endometrial cancer. Gynecol Oncol (1991) 1.94
Risk factors for pulmonary tuberculosis in Estonia. Int J Tuberc Lung Dis (2002) 1.92
Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol (2008) 1.91
Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst (1998) 1.91
Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod (1994) 1.91
Age-period-cohort models: a comparative study of available methodologies. J Clin Epidemiol (1999) 1.90